U.S. flag

An official website of the United States government

NM_001673.5(ASNS):c.1279T>C (p.Ser427Pro) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 21, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000412830.1

Allele description [Variation Report for NM_001673.5(ASNS):c.1279T>C (p.Ser427Pro)]

NM_001673.5(ASNS):c.1279T>C (p.Ser427Pro)

Genes:
CZ1P-ASNS:CZ1P-ASNS readthrough [Gene]
ASNS:asparagine synthetase (glutamine-hydrolyzing) [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q21.3
Genomic location:
Preferred name:
NM_001673.5(ASNS):c.1279T>C (p.Ser427Pro)
HGVS:
  • NC_000007.14:g.97853346A>G
  • NG_033870.2:g.80217T>C
  • NM_001178075.2:c.1216T>C
  • NM_001178076.2:c.1030T>C
  • NM_001178077.1:c.1030T>C
  • NM_001352496.2:c.1279T>C
  • NM_001673.5:c.1279T>CMANE SELECT
  • NM_133436.3:c.1279T>C
  • NM_183356.4:c.1279T>C
  • NP_001171546.1:p.Ser406Pro
  • NP_001171547.1:p.Ser344Pro
  • NP_001171548.1:p.Ser344Pro
  • NP_001339425.1:p.Ser427Pro
  • NP_001664.3:p.Ser427Pro
  • NP_597680.2:p.Ser427Pro
  • NP_899199.2:p.Ser427Pro
  • NC_000007.13:g.97482658A>G
  • NR_147989.1:n.2982T>C
Protein change:
S344P
Links:
dbSNP: rs1057518341
NCBI 1000 Genomes Browser:
rs1057518341
Molecular consequence:
  • NM_001178075.2:c.1216T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178076.2:c.1030T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178077.1:c.1030T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352496.2:c.1279T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001673.5:c.1279T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133436.3:c.1279T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_183356.4:c.1279T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147989.1:n.2982T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000491892GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Nov 21, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000491892.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The S427P variant in the ASNS gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is not observed in large population cohorts (Lek et al., 2016; McVean et al., 2012; Exome Variant Server) The S427P variant is a non-conservative amino acid substitution that occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. The S427P variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022